Genmab — Maj 2020
-
Up, up and away!! ^^
-
Novo, Zeal, Bava, Ambu m.fl falder tungt i dag.
-
the Ofatumumab
Autoinjector trial completed -nicely on time https://clinicaltrials.gov/ct2/history/NCT03560739?A=13&B=14&C=merged#StudyPageTop -
Rentschler er bare en alm CRO deal. Alle selskaber har sådan nogle deals. Det er genmab der betaler en CRO for at producere små batches antistoffer til div prækliniske og kliniske forsøg. No news
-
Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict https://www.fiercepharma.com/pharma/novartis-repurposed-leukemia-drug-tops-sanofi-s-aubagio-ms-study-weeks-ahead-fda-verdict
-
ASCO: Stay alert. Fradag kl. 14 er der virtuelle præsentationer af Epcoritamab, Amivantamab, TV og Teclistamab
-
Tak Pensionist.
-
God morgen
-
Ocrevus ned fra 3½ til 2 timers infusionstid https://www.inderes.fi/en/tiedotteet/roches-ocrevus-ocrelizumab-shorter-2-hour-infusion-time-approved-europe
-
Robothandel i Genmab 17,30 min. inde i udsendelsen. https://www.proinvestor.com/debat/84426
-
Markant bedre dag i end i går
-
hold da op noget vrøvl. Markant bedre dag i dag, end i går.
-
Lego -
Ocrevus er konkurrent til ofa ikke dara
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind